This study investigates the improvement of pregnancy management in women diagnosed with purulent-inflammatory diseases of the upper respiratory tract. These conditions, including sinusitis, tonsillitis, and pharyngitis, pose significant risks during pregnancy due to physiological and immunological changes that increase susceptibility to infection. The research aimed to evaluate the effectiveness of a comprehensive management approach combining safe antimicrobial therapy, local treatment, and continuous maternal–fetal monitoring.The study was conducted as a clinical observational analysis involving pregnant women with upper respiratory tract infections. Diagnostic methods included clinical examination, laboratory testing, and instrumental assessment. The treatment strategy was based on evidence-based protocols, ensuring both maternal safety and fetal well-being. The results demonstrated a significant reduction in symptom severity and duration, as well as normalization of inflammatory markers. Importantly, no significant increase in adverse obstetric outcomes was observed in the treated group.The findings highlight the importance of early diagnosis, rational pharmacotherapy, and a multidisciplinary approach in managing such conditions during pregnancy. Continuous fetal monitoring using ultrasound and cardiotocography played a key role in ensuring favorable outcomes. Although the study confirmed the safety and effectiveness of the proposed approach, further large-scale research is recommended to refine clinical guidelines.In conclusion, optimized management of purulent-inflammatory upper respiratory tract diseases in pregnant women contributes to improved maternal health and safe pregnancy outcomes.
Kadirova et al. (2026) studied this question.